These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 31285231)

  • 1. Genomic Analysis Identifies Novel Pseudomonas aeruginosa Resistance Genes under Selection during Inhaled Aztreonam Therapy
    McLean K; Lee D; Holmes EA; Penewit K; Waalkes A; Ren M; Lee SA; Gasper J; Manoil C; Salipante SJ
    Antimicrob Agents Chemother; 2019 Sep; 63(9):. PubMed ID: 31285231
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hypermutator Pseudomonas aeruginosa Exploits Multiple Genetic Pathways To Develop Multidrug Resistance during Long-Term Infections in the Airways of Cystic Fibrosis Patients.
    Colque CA; Albarracín Orio AG; Feliziani S; Marvig RL; Tobares AR; Johansen HK; Molin S; Smania AM
    Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32071060
    [No Abstract]   [Full Text] [Related]  

  • 3. Evolved Aztreonam Resistance Is Multifactorial and Can Produce Hypervirulence in
    Jorth P; McLean K; Ratjen A; Secor PR; Bautista GE; Ravishankar S; Rezayat A; Garudathri J; Harrison JJ; Harwood RA; Penewit K; Waalkes A; Singh PK; Salipante SJ
    mBio; 2017 Oct; 8(5):. PubMed ID: 29089424
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Penicillin-binding protein 3 is a common adaptive target among Pseudomonas aeruginosa isolates from adult cystic fibrosis patients treated with β-lactams.
    Clark ST; Sinha U; Zhang Y; Wang PW; Donaldson SL; Coburn B; Waters VJ; Yau YCW; Tullis DE; Guttman DS; Hwang DM
    Int J Antimicrob Agents; 2019 May; 53(5):620-628. PubMed ID: 30664925
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identification of Drug Resistance Determinants in a Clinical Isolate of Pseudomonas aeruginosa by High-Density Transposon Mutagenesis.
    Sonnabend MS; Klein K; Beier S; Angelov A; Kluj R; Mayer C; Groß C; Hofmeister K; Beuttner A; Willmann M; Peter S; Oberhettinger P; Schmidt A; Autenrieth IB; Schütz M; Bohn E
    Antimicrob Agents Chemother; 2020 Feb; 64(3):. PubMed ID: 31818817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudomonas aeruginosa chromosomal beta-lactamase in patients with cystic fibrosis and chronic lung infection. Mechanism of antibiotic resistance and target of the humoral immune response.
    Ciofu O
    APMIS Suppl; 2003; (116):1-47. PubMed ID: 14692154
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of Pseudomonas aeruginosa Antibiotic Resistance Genes Varies Greatly during Infections in Cystic Fibrosis Patients.
    Martin LW; Robson CL; Watts AM; Gray AR; Wainwright CE; Bell SC; Ramsay KA; Kidd TJ; Reid DW; Brockway B; Lamont IL
    Antimicrob Agents Chemother; 2018 Nov; 62(11):. PubMed ID: 30201819
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutations in β-Lactamase AmpC Increase Resistance of Pseudomonas aeruginosa Isolates to Antipseudomonal Cephalosporins.
    Berrazeg M; Jeannot K; Ntsogo Enguéné VY; Broutin I; Loeffert S; Fournier D; Plésiat P
    Antimicrob Agents Chemother; 2015 Oct; 59(10):6248-55. PubMed ID: 26248364
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of a new cephalosporin, CXA-101 (FR264205), against beta-lactam-resistant Pseudomonas aeruginosa mutants selected in vitro and after antipseudomonal treatment of intensive care unit patients.
    Moya B; Zamorano L; Juan C; Pérez JL; Ge Y; Oliver A
    Antimicrob Agents Chemother; 2010 Mar; 54(3):1213-7. PubMed ID: 20086158
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of extended spectrum beta-lactamases, metallo-beta-lactamases and AmpC-beta-lactamases among carbapenem resistant Pseudomonas aeruginosa isolated from burn patients.
    Neyestanaki DK; Mirsalehian A; Rezagholizadeh F; Jabalameli F; Taherikalani M; Emaneini M
    Burns; 2014 Dec; 40(8):1556-61. PubMed ID: 24767143
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of aztreonam in association with cefepime for the treatment of nosocomial infections due to multidrug-resistant strains of Pseudomonas aeruginosa to β-lactams in ICU patients: A pilot study.
    Dupont H; Marciniak S; Zogheib E; Mammeri H; Friggeri A; Ammenouche N; Levrard M; Airapetian N; Tinturier F; Mahjoub Y
    Anaesth Crit Care Pain Med; 2015 Jun; 34(3):141-4. PubMed ID: 26004874
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of Pseudomonas-Derived Cephalosporinase and Metallo-β-Lactamases in Carbapenem-Resistant Pseudomonas aeruginosa Isolates from Korea.
    Cho HH; Kwon GC; Kim S; Koo SH
    J Microbiol Biotechnol; 2015 Jul; 25(7):1154-62. PubMed ID: 25907063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deciphering β-lactamase-independent β-lactam resistance evolution trajectories in Pseudomonas aeruginosa.
    Cabot G; Florit-Mendoza L; Sánchez-Diener I; Zamorano L; Oliver A
    J Antimicrob Chemother; 2018 Dec; 73(12):3322-3331. PubMed ID: 30189050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Great phenotypic and genetic variation among successive chronic Pseudomonas aeruginosa from a cystic fibrosis patient.
    Lozano C; Azcona-Gutiérrez JM; Van Bambeke F; Sáenz Y
    PLoS One; 2018; 13(9):e0204167. PubMed ID: 30212579
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of ampD homologs in overproduction of AmpC in clinical isolates of Pseudomonas aeruginosa.
    Schmidtke AJ; Hanson ND
    Antimicrob Agents Chemother; 2008 Nov; 52(11):3922-7. PubMed ID: 18779353
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of Enzymatic Activity in the Biological Cost Associated with the Production of AmpC β-Lactamases in Pseudomonas aeruginosa.
    Barceló IM; Jordana-Lluch E; Escobar-Salom M; Torrens G; Fraile-Ribot PA; Cabot G; Mulet X; Zamorano L; Juan C; Oliver A
    Microbiol Spectr; 2022 Oct; 10(5):e0270022. PubMed ID: 36214681
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of carbapenem nonsusceptible Pseudomonas aeruginosa in Denmark: a nationwide, prospective study.
    Hansen F; Johansen HK; Østergaard C; Arpi M; Hansen DS; Littauer P; Holm A; Heltberg O; Schumacher H; Fuursted K; Lykke MA; Tønning B; Hammerum AM; Justesen US
    Microb Drug Resist; 2014 Feb; 20(1):22-9. PubMed ID: 23964748
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mutation of
    Zhao X; Jin Y; Bai F; Cheng Z; Wu W; Pan X
    Antimicrob Agents Chemother; 2022 Jul; 66(7):e0042122. PubMed ID: 35695577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Integron-encoded GES-type extended-spectrum beta-lactamase with increased activity toward aztreonam in Pseudomonas aeruginosa.
    Poirel L; Brinas L; Fortineau N; Nordmann P
    Antimicrob Agents Chemother; 2005 Aug; 49(8):3593-7. PubMed ID: 16048994
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diversity of β-lactam resistance mechanisms in cystic fibrosis isolates of Pseudomonas aeruginosa: a French multicentre study.
    Llanes C; Pourcel C; Richardot C; Plésiat P; Fichant G; Cavallo JD; Mérens A;
    J Antimicrob Chemother; 2013 Aug; 68(8):1763-71. PubMed ID: 23629014
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.